GIACOMELLI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 12.680
NA - Nord America 12.168
EU - Europa 8.707
SA - Sud America 1.269
AF - Africa 560
OC - Oceania 132
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.527
Nazione #
US - Stati Uniti d'America 11.547
CN - Cina 3.643
SG - Singapore 3.453
IT - Italia 2.920
VN - Vietnam 1.208
BD - Bangladesh 1.125
HK - Hong Kong 1.040
GB - Regno Unito 1.034
BR - Brasile 956
RU - Federazione Russa 815
DE - Germania 814
IN - India 598
FR - Francia 537
NL - Olanda 486
SE - Svezia 462
ES - Italia 383
ID - Indonesia 377
CA - Canada 365
FI - Finlandia 364
IE - Irlanda 242
JP - Giappone 215
KR - Corea 199
TR - Turchia 163
CI - Costa d'Avorio 156
MX - Messico 140
AU - Australia 125
PL - Polonia 99
AR - Argentina 85
ZA - Sudafrica 83
AT - Austria 80
DK - Danimarca 79
PK - Pakistan 75
PH - Filippine 69
CO - Colombia 66
BE - Belgio 63
IR - Iran 62
CH - Svizzera 57
TH - Thailandia 57
IQ - Iraq 55
MY - Malesia 51
TW - Taiwan 50
SA - Arabia Saudita 43
EC - Ecuador 41
UA - Ucraina 41
KE - Kenya 40
GH - Ghana 39
PE - Perù 38
EG - Egitto 37
PT - Portogallo 33
RO - Romania 32
NG - Nigeria 29
VE - Venezuela 26
CL - Cile 25
IL - Israele 24
MA - Marocco 21
ET - Etiopia 20
GR - Grecia 20
UZ - Uzbekistan 20
AE - Emirati Arabi Uniti 18
NP - Nepal 17
HU - Ungheria 16
TN - Tunisia 16
CZ - Repubblica Ceca 15
JM - Giamaica 15
GT - Guatemala 14
JO - Giordania 14
KZ - Kazakistan 14
PY - Paraguay 14
BW - Botswana 13
LT - Lituania 13
SC - Seychelles 13
CM - Camerun 12
BG - Bulgaria 11
BO - Bolivia 11
NO - Norvegia 11
TT - Trinidad e Tobago 11
UG - Uganda 11
AZ - Azerbaigian 10
LB - Libano 10
TZ - Tanzania 10
HN - Honduras 9
LU - Lussemburgo 9
MZ - Mozambico 9
NI - Nicaragua 9
CR - Costa Rica 8
DZ - Algeria 8
LK - Sri Lanka 8
LV - Lettonia 8
OM - Oman 8
SI - Slovenia 8
AM - Armenia 7
KH - Cambogia 7
MK - Macedonia 7
NZ - Nuova Zelanda 7
PR - Porto Rico 7
QA - Qatar 7
SL - Sierra Leone 7
SN - Senegal 7
SV - El Salvador 7
A2 - ???statistics.table.value.countryCode.A2??? 6
Totale 35.369
Città #
Singapore 1.934
Ashburn 1.509
Dallas 1.099
San Jose 835
Hong Kong 823
Milan 757
Chandler 661
Southend 587
Santa Clara 545
Beijing 535
Council Bluffs 516
Hefei 471
Los Angeles 435
Ho Chi Minh City 355
New York 341
Fairfield 302
Hanoi 286
Frankfurt am Main 280
Boardman 262
Rome 245
Helsinki 241
Dublin 238
Houston 236
Bengaluru 226
Buffalo 224
Valencia 222
Princeton 206
Lauterbourg 203
Jakarta 189
Ann Arbor 187
Guangzhou 171
Abidjan 156
Toronto 154
Moscow 146
Wilmington 146
The Dalles 141
Redwood City 140
Tokyo 127
Seoul 125
Shanghai 117
Chicago 111
Munich 111
Seattle 108
Woodbridge 102
Des Moines 101
São Paulo 99
Cambridge 95
Istanbul 93
Phoenix 90
Nuremberg 85
London 78
Cangzhou 73
Naples 69
Atlanta 65
Da Nang 64
Central District 63
Columbus 59
Warsaw 58
Washington 57
Dearborn 56
Bologna 51
Lappeenranta 51
Orem 51
Madrid 49
Nanjing 48
Haiphong 45
Turku 45
Turin 44
Chennai 43
Shenzhen 42
Amsterdam 41
Montreal 41
Mumbai 41
Tianjin 41
Boston 40
Berlin 39
Bodio Lomnago 38
Brooklyn 38
Brussels 38
Denver 38
San Diego 37
Palermo 36
Rio de Janeiro 36
Dong Ket 35
Salt Lake City 35
Vienna 35
Johannesburg 34
Paris 34
Sydney 33
San Francisco 32
Accra 30
Bangkok 30
Kuala Lumpur 29
Florence 28
Manchester 28
Mexico City 27
Taipei 27
Genoa 26
Lima 26
Belo Horizonte 25
Totale 19.497
Nome #
Self-reported symptoms of SARS-CoV-2 infection in a non-hospitalized population : results from the large Italian web-based EPICOVID19 cross-sectional survey. (Preprint) 567
Non-human primate and human malaria: past, present and future 554
Five years with dolutegravir plus lamivudine as a switch strategy : much more than a positive finding 451
Imported dengue fever: a 16-years retrospective analysis in Milan (Italy) and a brief review of the European literature 428
A case of crusted scabies with a delayed diagnosis and inadequate therapy 418
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19 : An International, Multicenter Retrospective Meta-analysis 417
Rapid COVID-19 Screening Based on Self-Reported Symptoms:Psychometric Assessment and Validation of the EPICOVID19Short Diagnostic Scale 392
Does syphilis increase the risk of HIV-RNA elevation >200 copies/mL in HIV positive patients under effective antiretroviral treatment? Data from the ICONA cohort 368
Clinical features and outcomes of HIV patients with coronavirus disease 2019 363
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 359
Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data 357
Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy 350
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study 342
Prevalence and factors associated with HIV-1 multidrug resistance over the past two decades in the Italian Arca database 326
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status 320
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022 311
Durability of INI-containing regimens after switching from PI-containing regimens : a single-centre cohort of drug-experienced HIV-infected subjects 290
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF 271
Retinal vessels modifications in acute and post-COVID-19 271
Differences in the prevalence of SARS-COV-2 infection and access to care between italians and non-italians in a social-housing neighbourhood of Milan, Italy 266
Clinical pharmacology in HIV cure research : what impact have we seen? 265
Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study 265
Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat 263
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study 258
Prevalence of extracardiac vascular complications in Abiotrophia spp. and Granulicatella spp. infective endocarditis: Two case reports and a systematic review 257
Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study 252
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 251
Clinical and genetic determinants of nevirapine plasma trough concentration 248
Association between smoking and sars-cov-2 infection: Cross-sectional study of the epicovid19 internet-based survey 243
Retinal findings in patients with COVID-19: Results from the SERPICO-19 study 242
Imported Dengue Fever in Milan, Italy: A seven-year retrospective study 241
Delayed diagnosis among patients with cutaneous and mucocutaneous leishmaniasis 239
Redefining the Prognostic Value of High-Sensitivity Troponin in COVID-19 Patients: The Importance of Concomitant Coronary Artery Disease 239
Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry 234
Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review 233
Dengue fever complicated by liver dysfunction due to possible co-infection with hepatitis E in a returning traveller from Cuba 231
An update on integrase inhibitors : new opportunities for a personalized therapy? The NEXTaim Project 230
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 229
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 227
Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA) 226
Circulating endothelial progenitors are increased in Covid‐19 patients and correlate with SARS‐CoV‐2 RNA in severe cases 225
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: a retrospective cohort study 225
Correlation between continuous Positive end-expiratory pressure (PEEP) values and occurrence of Pneumothorax and Pneumomediastinum in SARS-CoV2 patients during non-invasive ventilation with Helmet 222
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 221
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients 219
Mortality rates among COVID-19 patients hospitalised during the first three waves of the epidemic in Milan, Italy: A prospective observational study 215
Drug-drug interactions between tirzepatide and antiretrovirals: time to reassess and reassure? 214
A comparison between two dolutegravir-based two-drug regimens as switch strategies in a multicentre cohort of HIV-1-infected patients 214
Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections 210
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 210
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation 209
Missed opportunities of flu vaccination in Italian target categories: Insights from the online epicovid 19 survey 209
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 204
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation 202
Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis – results from the ICONA cohort in Italy, 2009-2022 200
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 200
Unexpectedly High Frequency of Enterococcal Bloodstream Infections in Coronavirus Disease 2019 Patients Admitted to an Italian ICU: An Observational Study 199
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine 198
Multidrug-resistant HIV viral rebound during early syphilis: a case report 195
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis 194
Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy 193
The Association between Influenza and Pneumococcal Vaccinations and SARS-Cov-2 Infection : Data from the EPICOVID19 Web-Based Survey 192
Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data 191
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition : The “ImpACT-COVID-19 for Patients” Multi-Centre Observational Study 191
Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities 190
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy 188
Viral bloodstream detection in mpox patients: An observational multicentric study 187
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens 186
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 186
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 185
Screening for Chagas disease in Latin-American pregnant women and their newborns: A prospective observational, multicenter study in Milan, Italy 185
Hospitalisation for monkeypox in Milan, Italy 184
Early results from implementation of HIV pre-exposure prophylaxis (PrEP) with long-acting injectable cabotegravir for people with barriers to oral strategies, Italy, December 2024 to August 2025 184
The value of lamp to rule out imported malaria diagnosis: a retrospective observational study in Milan, Italy 184
Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older 182
Histoplasmosis diagnosed in Europe and Israel: A case report and systematic review of the literature from 2005 to 2020 182
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced dimalsease: a trial emulation 181
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection 181
Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? 181
Influenza Vaccination Uptake in the General Italian Population during the 2020–2021 Flu Season: Data from the EPICOVID-19 Online Web-Based Survey 180
Age-Related Changes in Clinical Presentation of Covid19: the EPICOVID19 Web-Based Survey 179
Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient 178
Delayed psychotropic toxicity after switching from nevirapine to bictegravir: the role of enzyme de-induction in people with HIV and polypharmacy 177
Endemic mycoses: geographical distribution is still a work in progress 176
Accessibility to SARS-CoV-2 swab test during the Covid-19 pandemic : Did age make the difference? 174
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus 173
Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients : Potential implications for clinical practice 173
Detecting HCV infection by means of mass population SARS-CoV-2 screening: a pilot experience in Northern Italy 173
Factors involved in continuance of atazanavir-based regimens : Results from a cohort of HIV1-positive patients 169
Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves 167
Cryptococcal Disease Presenting With Cellulitis in Kidney Transplant Recipients 165
Impact of gender on patients hospitalized for SARS-COV-2 infection: A prospective observational study 164
Effectiveness and safety of tenofovir alafenamide/emtricitabine/bictegravir as a first-line regimen in people with HIV: A retrospective observational study 162
COVID-19 Vaccine Hesitancy among Unvaccinated Adults: A Cross-Sectional Exploratory Analysis of Vaccination Intentions in Italy Related to Fear of Infection 160
Chagas disease prevalence among migrants from El Salvador in Milan: a cross- sectional study of an often-overlooked population 158
Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500,000 copies/mL in 2018-2023 in Italy: data from the ICONA Foundation Cohort Study 157
Preventing HIV mother-to-child transmission in a vertically infected pregnant woman with multiclass drug resistance, role of bis-in-die dolutegravir and neonatal AZT prophylaxis: A case report 154
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study 154
Reply to Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience from the Latindili Network" by Bessone Fernando et al 154
Bacterial coinfections in COVID-19 patients without a positive microbiologic result : a word of caution 154
Totale 23.513
Categoria #
all - tutte 110.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.476 144 182 163 166 212 229 219 172 301 174 126 388
2022/20232.755 275 262 230 278 249 473 116 157 310 56 250 99
2023/20242.823 155 173 153 209 555 287 186 125 128 167 292 393
2024/20256.548 256 629 131 545 469 311 292 549 369 851 729 1.417
2025/202617.783 1.527 1.714 2.121 1.502 1.226 897 2.103 746 1.502 1.236 1.659 1.550
2026/2027921 921 0 0 0 0 0 0 0 0 0 0 0
Totale 36.770